Current
$173M
5-Year Average
$158M
All-Time High
$458M
All-Time Low
$18.1M
Market cap daily chart for Ovid Therapeutics (OVID)
Jul 28, 2021 – Jul 27, 2026 · 1,254 trading days
Market Cap growth chart for Ovid Therapeutics (OVID) from 2017 to 2026
Latest: +44.2%
Market Cap history table for Ovid Therapeutics (OVID) from 2017 to 2026
| 2026 | $173M | +44.2% | +$53.1M | ||
| 2025 | $120M | +81.5% | +$54M | ||
| 2024 | $66.2M | -70.9% | -$161M | ||
| 2023 | $227M | +73.5% | +$96.3M | ||
| 2022 | $131M | -40.0% | -$87.5M | ||
| 2021 | $218M | +61.8% | +$83.5M | ||
| 2020 | $135M | -17.0% | -$27.7M | ||
| 2019 | $163M | +173.0% | +$103M | ||
| 2018 | $59.6M | -68.8% | -$131M | ||
| 2017 | $191M | — | — |
- 2026$173M+44.2%
- 2025$120M+81.5%
- 2024$66.2M-70.9%
- 2023$227M+73.5%
- 2022$131M-40.0%
- 2021$218M+61.8%
- 2020$135M-17.0%
- 2019$163M+173.0%
- 2018$59.6M-68.8%
- 2017$191M—
Market Cap values are taken from Ovid Therapeutics's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Ovid Therapeutics (OVID)
According to Ovid Therapeutics's latest reported financial statements, the company's latest reported market cap is $164M. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2026's annual market cap for Ovid Therapeutics (OVID) came in at $173M – surged 44.2% year-over-year.
Ovid Therapeutics market cap has grown for 2 consecutive years, with a -4.5% compound annual growth rate over 2021–2026 (5 years).
Between 2023 and 2026, Ovid Therapeutics market cap declined 23.8%, falling from $227M to $173M.
The record annual market cap stands at $227M, reached in 2023; the historical low of $59.6M was recorded in 2018.
Ovid Therapeutics Market Cap by Year
Ovid Therapeutics Market Cap 2026: $173M
Ovid Therapeutics posted market cap of $173M in 2026, surged 44.2% from 2025.
Ovid Therapeutics Market Cap 2025: $120M
In 2025, Ovid Therapeutics reported market cap of $120M, surged 81.5% from 2024.
Ovid Therapeutics Market Cap 2024: $66.2M
Ovid Therapeutics market cap in 2024 was $66.2M, plunged 70.9% below 2023.
Ovid Therapeutics Market Cap 2023: $227M
2023's market cap for Ovid Therapeutics came in at $227M, surged 73.5% from 2022. This figure represents the highest annual value in the available history.
Ovid Therapeutics Market Cap 2022: $131M
Ovid Therapeutics market cap in 2022 was $131M.
See more financial history for Ovid Therapeutics (OVID).
Sector peers by Market Cap
Healthcare peers of Ovid Therapeutics (OVID), ranked by their latest market cap
| $1.13T | |
| $640B | |
| $454B | |
| $379B | |
| $323B | |
| $221B | |
| $208B | |
| $203B |
- $1.13T
- $454B
- $323B
- $221B
- $203B
Frequently asked questions
Test yourself on OVID
Market Cap — 10 rounds, every one of them OVID against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Ovid Therapeutics (OVID) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.